GILEAD SCIENCES, INC. is 6.9x more valuable than BioNTech SE by market capitalization ($151.05 B vs $21.79 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GILD | BNTX |
|---|---|---|
| Market cap | $151.05 B | $21.79 B |
| US-listed rank | #99 | #587 |
| Revenue (latest FY) | $29.44B | - |
| Net income (latest FY) | $8.51B | - |
| Net margin | 28.9% | - |
| P/E (trailing FY) | 17.7 | - |
| SEC filings | 981 | 548 |
GILEAD SCIENCES, INC. is 6.9x more valuable than BioNTech SE by market capitalization ($151.05 B vs $21.79 B).
Full pages: GILEAD SCIENCES, INC. and BioNTech SE, or browse the full rankings.